Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors - 15/02/21
Doi : 10.1016/j.jaad.2020.09.096
Leah L. Thompson, BA a, b, Catherina X. Pan, BA a, b, Michael S. Chang, BA a, b, Nira A. Krasnow, BS a, b, Amy E. Blum, MA a, b, Steven T. Chen, MD, MPH, MS-HPEd a, b, ⁎ 
a Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
∗Reprint requests: Steven T. Chen, MD, MPH, MS-HPEd, Department of Dermatology, 50 Staniford St, Ste 200, Boston, MA 02114Department of Dermatology50 Staniford St, Ste 200BostonMA02114
| Drs Thompson and Pan are cofirst authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Approved by the Partners Health IRB (protocol no. 2017P000501). |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 3
P. 851-854 - mars 2021 Retour au numéro
Article précédent
- Trends in Medicare Part D prescription claims for biologic and nonbiologic immunosuppressive medications by dermatologists
- Christian Gronbeck, Paula W. Feng, Hao Feng
- Translational research on the role of formula stability in Hetter's phenol–croton oil peels: Analysis of chemical studies and clinical outcomes from a randomized, double-blinded, split-face controlled trial
- Ideli Cristhina Neitzke, Daniella de Grande Curi, Erica Miyake Lin, Kachiu Cecilia Lee, Seaver L. Soon, Ana Cecília Lunardelli Bittencourt, Caroline Motta Aguiar, Domingos Jordão Neto, Amanda Roderjan Cray da Costa Filha, Flávio Luís Beltrame, Patrícia Mathias Döll-Boscardin, Carlos Gustavo Wambier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?